-
Endpoints News2 weeks ago
Gilgamesh’s psychedelics pipeline gets $60M backing after AbbVie deal
Investors have pumped $60 million into Gilgamesh Pharma to test a handful of psychedelics and other experimental neuroscience medicines that the biotech hasn’t yet promised to...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Genomic Mapping of E. coli Capsules Identifies High-Risk Types for Vaccines
A sweeping genomic survey is offering the clearest picture yet of how Escherichia coli uses its protective capsule to evade the immune system—and which capsule types...
-
Uncategorized2 weeks agoLilly’s triple agonist significantly reduces A1C and weight
Eli Lilly has announced positive topline results from TRANSCEND-T2D-1, a Phase III clinical trial evaluating the efficacy and safety of retatrutide, an investigational first-in-class GIP, GLP-1...
-
AI & Machine Learning in Biotechnology2 weeks ago
Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the New Jersey Big Pharma.Read More
-
Fierce Biotech2 weeks ago
Sarepta’s big bet on Arrowhead’s siRNA assets yields early data
Sarepta Therapeutics has shared initial clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision to bet big on Arrowhead...
-
Uncategorized2 weeks agoStudy supports Treg enhancement as dementia treatment
A research study led by Dr Alireza Faridar and Dr Stanley Appel at the Houston Methodist Neurological Institute has demonstrated the involvement of the peripheral immune...
-
STAT News – Biotech2 weeks agoSTAT+: How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward
Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech called Loxo Oncology, and his boss,...
-
STAT News – Biotech2 weeks agoOpinion: The U.S. needs to be worried about Iranian biological materials
The war with Iran has focused the world’s attention on nuclear weapons and oil. Those risks are real. But there is a third category of danger...
-
STAT News – Biotech2 weeks agoSTAT+: Qualified Health raises $125 million, as it helps more health systems build and manage AI tools
It was 2023. ChatGPT had been released less than five months earlier. Justin Norden was sitting around a table with a dozen health care leaders at...
-
STAT News – Biotech2 weeks agoOpinion: Emergency departments are not equipped to help patients with dementia
I recently spent a long afternoon hiding from the nurse in the emergency room of a prestigious hospital. My sister and I were there with my...
